Following a period of increased clinical activity, Q422, as we noted previously, saw Cantargia narro...
Learning to Sleep publicerade den 23 februari år 2023 bolagets delårsrapport för det fjärde kvartale...
Redeye is positively surprised by the favorable opinion for Tesofensine as an obesity treatment in M...
ADDvise, som förvärvar bolag inom hälso- och sjukvård, bjöd på rekordsiffror i sin bokslutskommuniké...
Redeye provides an update on Northbaze's Q4 2022 report.
Redeye leaves its comments on Idogen following its Q4 report.
After a comprehensive adjustment of business focus, balance sheet, costs and valuation in 2022, alon...
With another NLAW order, from Finland of SEK 400m, Saab’s delivery timeline support a revenue scenar...
Calliditas recorded Q4 Tarpeyo sales of SEK 169m which is impressive even if it is just below our an...
Redeye states that Sensys Gatso has gained strong momentum during 2022, resulting in a record high o...
Redeye updates its estimates on the back of I-Tech’s Q4’22 report, delivering a significant estimate...
Redeye retains its positive view of Binero following the Q4 2022 report.
Redeye updates its estimates and fair value range following the Q4 report, which showed higher profi...
Redeye has provided an update on Strax's Q4 2022 report and the management team's strategic plan for...
Q4'22: Pre-tax profit in line with expectations Jumbo dividend of DKK 26 offers a yield of 14.
Expect DKK 51m in sales and EBITDAC of DKK -5m Looks set to reach new milestones in 2023 Fair value ...
AcuCort publicerade den 24 februari bolagets delårsrapport för det fjärde kvartalet år 2022 och står...
Qlosr publicerade den 24 februari 2023 bolagets delårsrapport för det fjärde kvartalet år 2022 och ö...
Flowscape drabbades av hårdvarubrist under Q4 vilket påverkade försäljningen.
Maven Wireless publicerade den 24 februari 2023 bolagets delårsrapport för fjärde kvartalet år 2022 ...
